Dermatofibrosarcoma Protuberans in Pediatric Patients: A Diagnostic and Management Challenge

Overview

Journal JAAD Case Rep

Specialty Dermatology

Date 2018 Feb 2

PMID 29387771

Citations 8

Authors

Anna H Buteau

Brett H Keeling

Lucia Z Diaz

Margarita Larralade

Paula Luna

Chandra Krishnan

Moise L Levy

Affiliations

Soon will be listed here.

Citing Articles

Surgical Management of Pediatric Dermatofibrosarcoma Protuberans: About Two Challenging Case Reports.

Zouirech Y, Manni A, Rouijel B, El Baoudi A, El Agouri H, Fejjal N Glob Pediatr Health. 2024; 11:2333794X241286916.

PMID: 39372491 PMC: 11450917. DOI: 10.1177/2333794X241286916.

Anterior Abdominal Wall Dermatofibrosarcoma Protuberans: A Rare Case.

Shah B, Vijendra A Cureus. 2024; 16(8):e66627.

PMID: 39258060 PMC: 11386355. DOI: 10.7759/cureus.66627.

Molecular pathways and therapeutic strategies in dermatofibrosarcoma protuberans (DFSP): unravelling the tumor's genetic landscape.

Singh H, Choudhary H, Mandlik D, Magre M, Mohanto S, Ahmed M EXCLI J. 2024; 23:727-762.

PMID: 38983783 PMC: 11231459. DOI: 10.17179/excli2024-7164.

Paediatric dermatofibrosarcoma protuberan-a case report in an Afro-Caribbean boy.

Neblett C, Appiah K, Jones J, Lawrence T, Dawkins S, Crookendale G J Surg Case Rep. 2024; 2024(2):rjae062.

PMID: 38370593 PMC: 10871767. DOI: 10.1093/jscr/rjae062.

A study of collagen refractility in dermatofibroma and dermatofibrosarcoma protuberans using diffractive microscopy.

Brailsford C, Khamdan F, Dirr M, Sagut P, Nietert P, Elston D J Cutan Pathol. 2023; 51(4):306-310.

PMID: 38124386 PMC: 10922144. DOI: 10.1111/cup.14577.

References

Cribier B, Noacco G, Peltre B, Grosshans E . Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol. 2002; 46(3):408-13. DOI: 10.1067/mjd.2002.119656. View

Del Carmen Gomez-Mateo M, Monteagudo C . Nonepithelial skin tumors with multinucleated giant cells. Semin Diagn Pathol. 2013; 30(1):58-72. DOI: 10.1053/j.semdp.2012.01.004. View

Loeb D, Thornton K, Shokek O . Pediatric soft tissue sarcomas. Surg Clin North Am. 2008; 88(3):615-27, vii. PMC: 4273573. DOI: 10.1016/j.suc.2008.03.008. View

Kutzner H, Mentzel T, Palmedo G, Hantschke M, Rutten A, Paredes B . Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma.... Am J Surg Pathol. 2010; 34(2):190-201. DOI: 10.1097/PAS.0b013e3181c7cf11. View

Tsai Y, Lin P, Chew K, Chiang Y . Dermatofibrosarcoma protuberans in children and adolescents: Clinical presentation, histology, treatment, and review of the literature. J Plast Reconstr Aesthet Surg. 2014; 67(9):1222-9. DOI: 10.1016/j.bjps.2014.05.031. View

Kraus M, HALEY J, Ruiz R, Essary L, Moran C, Fletcher C . "Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol. 2001; 23(2):104-11. DOI: 10.1097/00000372-200104000-00004. View

Rouhani P, Fletcher C, Devesa S, Toro J . Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer. 2008; 113(3):616-27. DOI: 10.1002/cncr.23571. View

Kutzner H . Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol. 1993; 28(4):613-7. DOI: 10.1016/0190-9622(93)70083-6. View

Marque M, Bessis D, Pedeutour F, Viseux V, Guillot B, Fraitag-Spinner S . Medallion-like dermal dendrocyte hamartoma: the main diagnostic pitfall is congenital atrophic dermatofibrosarcoma. Br J Dermatol. 2008; 160(1):190-3. DOI: 10.1111/j.1365-2133.2008.08896.x. View

10.

Valdivielso-Ramos M, Torrelo A, Campos M, Feito M, Gamo R, Rodriguez-Peralto J . Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes. Pediatr Dermatol. 2014; 31(6):676-82. DOI: 10.1111/pde.12371. View

11.

Karanian M, Perot G, Coindre J, Chibon F, Pedeutour F, Neuville A . Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans. Mod Pathol. 2014; 28(2):230-7. DOI: 10.1038/modpathol.2014.97. View

12.

Kornik R, Muchard L, Teng J . Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment. Pediatr Dermatol. 2012; 29(6):707-13. DOI: 10.1111/j.1525-1470.2012.01767.x. View

13.

Llombart B, Serra-Guillen C, Monteagudo C, Lopez Guerrero J, Sanmartin O . Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013; 30(1):13-28. DOI: 10.1053/j.semdp.2012.01.002. View

14.

Hoesly P, Lowe G, Lohse C, Brewer J, Lehman J . Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study. J Am Acad Dermatol. 2015; 72(3):419-25. DOI: 10.1016/j.jaad.2014.11.020. View

15.

Llombart B, Sanmartin O, Lopez-Guerrero J, Monteagudo C, Serra C, Requena C . Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications. Histopathology. 2009; 54(7):860-72. DOI: 10.1111/j.1365-2559.2009.03310.x. View